BioSpace News Archive

NuProbe Global, a genomics and molecular diagnostics company specialized in ultrasensitive oncology assays, announced research on DNA microsatellites published today in Nucleic Acids Research. Simultaneously, the company announced the release of the VarTrace® MSI qPCR research use only assay for detection of DNA microsatellite instability (MSI) from tissue or blood specimens.

PulmoSIM Therapeutics (PulmoSIM), the pharmaceutical subsidiary of VeriSIM Life, Inc., is pleased to announce today that it has entered into a strategic partnership with the investigators from National Jewish Health and Brown University for the clinical development of PT001, a drug that targets multiple responsible pathways in PAH to provide curative treatment.

Evren Technologies, Inc. announced today that its non-invasive Phoenix® earbud device received Breakthrough Device Designation from the U.S. Food and Drug Administration for the treatment of Post-traumatic Stress Disorder (PTSD).

Biogen (Nasdaq: BIIB) and Eisai Co., Ltd. (Tokyo, Japan) today announced that Biogen, as part of its Alzheimer’s disease (AD) research portfolio, will contribute four virtual posters that showcase data from its clinical trials with ADUHELM™ (aducanumab-avwa) injection 100 mg/mL solution at the Alzheimer’s Association International Conference (AAIC),

Imago BioSciences, Inc. (“Imago”) (NASDAQ: IMGO), a clinical stage biopharmaceutical company discovering new medicines for the treatment of myeloproliferative neoplasms (MPNs), today announced that in connection with its previously announced public offering of its common stock, the underwriters have exercised their option to purchase an additional 1,260,000 shares of common stock from the Company.

INmune Bio, Inc. today announced the design of its upcoming Phase 2 clinical trial of XProTM in patients diagnosed with mild Alzheimer’s disease (AD).

Sharecare will participate in the 41st Annual Canaccord Genuity Growth Conference, including a presentation on Thursday, August 12, 2021

OncoSec Medical Incorporated today announced that Interim CEO and Chief Operating Officer, Brian Leuthner , and Senior Vice President, Chief Clinical Development Officer, Sandra Aung , Ph.D., will participate in a fireside chat at the BTIG Virtual Biotechnology Conference

Laboratory water purification system is used to produce water of application-specific quality.

Urodynamic studies determine how the bladder, sphincters, and urethra hold and release urine.